Viewbix Moves to Acquire Quantum X Labs
Advanced technologies company Viewbix Inc. is moving forward with its acquisition of Israel's Quantum X Labs. The company signed a definitive agreement in late 2025 to acquire 85–100% of the multi-disciplinary quantum hub. Recent milestones include securing majority stockholder approval for the transaction.
- This acquisition marks a significant strategic pivot for Viewbix, which has historically operated in the digital advertising and media sector, into the deep-tech field of quantum computing. - The deal is structured with an initial issuance of Viewbix common stock and pre-funded warrants, with additional stock consideration of up to 25% contingent on Quantum X Labs achieving specific post-closing milestones. - A concurrent $3 million PIPE (Private Investment in Public Equity) financing was announced to support the acquisition and the company's evolving operations. - Quantum X Labs is not a single entity but a hub with a portfolio of companies working on diverse quantum applications, including GPS-denied navigation, quantum error correction, and platforms for biomedical research. - A key piece of intellectual property included in the acquisition is a patent for AI-Quantum Error Correction, developed in collaboration with Ramot, the technology transfer company of Tel Aviv University, which claims to reduce computational overhead by up to 50%. - The acquisition is expected to close within 90 days of the definitive agreement's execution on December 15, 2025, pending regulatory and final stockholder approvals. - In a move to streamline its focus on this new direction, Viewbix completed the sale of its Cortex Media Group subsidiary to a unit of Minute Media Inc. - Quantum X Labs has also filed a U.S. patent for a quantum-enhanced statistical sampling method (Quantum Markov Chain Monte Carlo) aimed at accelerating and improving the analysis of clinical trial data.